Protara Therapeutics Inc. (TARA)
TARA trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.62
-5.42% on the day
Market cap
$154.8M
Micro cap
Revenue
No annual revenue filed since the period ending 2014-12-31
Net income
No annual revenue filed since the period ending 2014-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | TARA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2014 |
| SEC CIK | 0001359931 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DELAWARE |
Financials
No annual revenue filed since the period ending 2014-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-05-28 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-10 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-11 |
| Latest current report CURRENT REPORT | 8-K | 2026-08-11 |
| Latest proxy DEFINITIVE ADDITIONAL MATERIALS | DEFA14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 809 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CMPX | Compass Therapeutics Inc. | $0.8570 | -8.59% | $154.3M |
| IPHA | Innate Pharma S.A. ADS | $1.47 | -0.68% | $164.2M |
| CHRS | Coherus Oncology Inc. | $1.07 | +3.88% | $165.3M |
| CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $1.20 | +1.70% | $144.8M |
| DTIL | Precision BioSciences Inc. | $6.10 | -6.58% | $168.4M |
| MOLN | Molecular Partners AG | $3.67 | -3.17% | $137.7M |
| OTLK | Outlook Therapeutics Inc. | $0.5638 | -3.64% | $137.3M |
| AVXL | Anavex Life Sciences Corp. | $1.48 | -1.99% | $137.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier